Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Healthy Volunteer|Prostate Cancer|Head and Neck Cancer|Esophageal Cancer|Genitourinary Cancer|Sarcoma|Breast Cancer|Colon Cancer|Gastrointestinal Cancer|Solid Tumor Cancer|Lung Cancer|Skin Cancer|Melanoma
Sponsor: Washington University School of Medicine
Collaborators: Roche Sequencing Solutions|The Foundation for Barnes-Jewish Hospital|National Center for Advancing Translational Sciences (NCATS)|Radiological Society of North America|Skandalaris|The V Foundation for Cancer Research|National Institute of General Medical Sciences (NIGMS)